Skip to main content
Top

12-12-2023 | Kawasaki Disease | Review Article

The Intricate Dance of Infections and Autoimmunity: An Interesting Paradox

Authors: Anand Prahalad Rao, Debasis Patro

Published in: Indian Journal of Pediatrics

Login to get access

Abstract

Besides genetic susceptibility, infections due to viruses, bacteria and protozoa have been implicated in the development of autoimmune diseases (AD). AD can be triggered in a genetically susceptible individual by infections that disrupt immunological tolerance towards self-antigens. Pathogens can initiate autoimmunity by way of molecular mimicry, bystander activation, epitope spreading or persistent infection with polyclonal activation. This review covers two main topics: (i) the mechanisms by which an infectious agent can trigger or worsen autoimmunity; and (ii) the correlation between specific infectious agents and AD in humans with special emphasis on multisystem inflammatory syndrome in children (MIS-C).
Literature
1.
go back to reference Tangye SG, Al-Herz W, Bousfiha A, et al. Human inborn errors of immunity: 2022 update on the classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2022;42:1473–507.CrossRefPubMedPubMedCentral Tangye SG, Al-Herz W, Bousfiha A, et al. Human inborn errors of immunity: 2022 update on the classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2022;42:1473–507.CrossRefPubMedPubMedCentral
2.
go back to reference Schoenfeld Y, Isenberg D. The mosaic of autoimmunity. Immunol Today. 1989;10:123–6.CrossRef Schoenfeld Y, Isenberg D. The mosaic of autoimmunity. Immunol Today. 1989;10:123–6.CrossRef
3.
go back to reference Floreani A, Leung PS, Gershwin ME. Environmental basis of autoimmunity. Clin Rev Allergy Immunol. 2016;50:287–300.CrossRefPubMed Floreani A, Leung PS, Gershwin ME. Environmental basis of autoimmunity. Clin Rev Allergy Immunol. 2016;50:287–300.CrossRefPubMed
4.
go back to reference Delogu LG, Deidda S, Delitala G, Manetti R. Infectious diseases and autoimmunity. J Infect Dev Ctries. 2011;5:679–87.CrossRefPubMed Delogu LG, Deidda S, Delitala G, Manetti R. Infectious diseases and autoimmunity. J Infect Dev Ctries. 2011;5:679–87.CrossRefPubMed
5.
go back to reference Kivity S, Agmon-Levin N, Blank M, Shoenfeld Y. Infections and autoimmunity - friends or foes? Trends Immunol. 2009;30:409–14.CrossRefPubMed Kivity S, Agmon-Levin N, Blank M, Shoenfeld Y. Infections and autoimmunity - friends or foes? Trends Immunol. 2009;30:409–14.CrossRefPubMed
6.
go back to reference Kudat H, Telci G, Sozen AB, et al. The role of HLA molecules in susceptibility to chronic rheumatic heart disease. Int J Immunogenet. 2006;33:41–4.CrossRefPubMed Kudat H, Telci G, Sozen AB, et al. The role of HLA molecules in susceptibility to chronic rheumatic heart disease. Int J Immunogenet. 2006;33:41–4.CrossRefPubMed
7.
go back to reference Wanstrat A, Wakeland E. The genetics of complex autoimmune diseases: Non-MHC susceptibility genes. Nat Immunol. 2001;2:802–9.CrossRef Wanstrat A, Wakeland E. The genetics of complex autoimmune diseases: Non-MHC susceptibility genes. Nat Immunol. 2001;2:802–9.CrossRef
8.
go back to reference Galli L, Chiappini E, de Martino M. Infections and autoimmunity. Pediatr Infect Dis J. 2012;31:1295–7.CrossRefPubMed Galli L, Chiappini E, de Martino M. Infections and autoimmunity. Pediatr Infect Dis J. 2012;31:1295–7.CrossRefPubMed
9.
go back to reference Anaya J-M, Shoenfeld Y, Rojas-Villarraga A, Levy RA, Cervera R. Autoimmunity: From Bench to Bedside [Internet]. Bogota (Colombia): El Rosario University Press; 2013 Jul 18. PMID: 29087650. Anaya J-M, Shoenfeld Y, Rojas-Villarraga A, Levy RA, Cervera R. Autoimmunity: From Bench to Bedside [Internet]. Bogota (Colombia): El Rosario University Press; 2013 Jul 18. PMID: 29087650.
10.
go back to reference Arbuckle MR, McClain MT, Rubertone MV, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. New Engl J Med. 2003;349:1526–33.CrossRefPubMed Arbuckle MR, McClain MT, Rubertone MV, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. New Engl J Med. 2003;349:1526–33.CrossRefPubMed
11.
go back to reference Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395:1607–8.CrossRefPubMedPubMedCentral Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395:1607–8.CrossRefPubMedPubMedCentral
12.
go back to reference Verdoni L, Mazza A, Gervasoni A, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: An observational cohort study. Lancet. 2020;395:1771–8.CrossRefPubMedPubMedCentral Verdoni L, Mazza A, Gervasoni A, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: An observational cohort study. Lancet. 2020;395:1771–8.CrossRefPubMedPubMedCentral
13.
go back to reference McMurray JC, May JW, Cunningham MW, Jones OY. Multisystem inflammatory syndrome in children (MIS-C), a post-viral myocarditis and systemic vasculitis—a critical review of its pathogenesis and treatment. Front Pediatr. 2020;8:626182.CrossRefPubMedPubMedCentral McMurray JC, May JW, Cunningham MW, Jones OY. Multisystem inflammatory syndrome in children (MIS-C), a post-viral myocarditis and systemic vasculitis—a critical review of its pathogenesis and treatment. Front Pediatr. 2020;8:626182.CrossRefPubMedPubMedCentral
14.
15.
go back to reference Carter MJ, Fish M, Jennings A, et al. Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection. Nat Med. 2020;26:1701–7.CrossRefPubMed Carter MJ, Fish M, Jennings A, et al. Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection. Nat Med. 2020;26:1701–7.CrossRefPubMed
16.
go back to reference Lee PY, Day-Lewis M, Henderson LA, et al. Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children. J Clin Invest. 2020;130:5942–50.CrossRefPubMedPubMedCentral Lee PY, Day-Lewis M, Henderson LA, et al. Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children. J Clin Invest. 2020;130:5942–50.CrossRefPubMedPubMedCentral
17.
go back to reference Shulman ST. Pediatric coronavirus disease-2019–associated multisystem inflammatory syndrome. J Pediatric Infect Dis Soc. 2020;9:285–6.CrossRefPubMed Shulman ST. Pediatric coronavirus disease-2019–associated multisystem inflammatory syndrome. J Pediatric Infect Dis Soc. 2020;9:285–6.CrossRefPubMed
18.
go back to reference Sharma C, Ganigara M, Galeotti C, et al. Multisystem inflammatory syndrome in children and Kawasaki disease: A critical comparison. Nat Rev Rheumatol. 2021;17:731–48.CrossRefPubMedPubMedCentral Sharma C, Ganigara M, Galeotti C, et al. Multisystem inflammatory syndrome in children and Kawasaki disease: A critical comparison. Nat Rev Rheumatol. 2021;17:731–48.CrossRefPubMedPubMedCentral
19.
go back to reference Diorio C, McNerney KO, Lambert M, et al. Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentations. Blood Adv. 2020;4:6051–63.CrossRefPubMedPubMedCentral Diorio C, McNerney KO, Lambert M, et al. Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentations. Blood Adv. 2020;4:6051–63.CrossRefPubMedPubMedCentral
20.
go back to reference Kaushik S, Aydin SI, Derespina KR, et al. Multisystem inflammatory syndrome in children associated with severe acute respiratory syndrome coronavirus 2 infection (MIS-C): A multi-institutional study from New York City. J Pediatr. 2020;224:24–9.CrossRefPubMedPubMedCentral Kaushik S, Aydin SI, Derespina KR, et al. Multisystem inflammatory syndrome in children associated with severe acute respiratory syndrome coronavirus 2 infection (MIS-C): A multi-institutional study from New York City. J Pediatr. 2020;224:24–9.CrossRefPubMedPubMedCentral
21.
go back to reference Ouldali N, Toubiana J, Antona D, et al; French Covid-19 Paediatric Inflammation Consortium. Association of intravenous immunoglobulins plus methylprednisolone vs immunoglobulins alone with course of fever in multisystem inflammatory syndrome in children. JAMA. 2021;325:855–64.CrossRefPubMed Ouldali N, Toubiana J, Antona D, et al; French Covid-19 Paediatric Inflammation Consortium. Association of intravenous immunoglobulins plus methylprednisolone vs immunoglobulins alone with course of fever in multisystem inflammatory syndrome in children. JAMA. 2021;325:855–64.CrossRefPubMed
22.
go back to reference Nakra NA, Blumberg DA, Herrera-Guerra A, Lakshminrusimha S. Multi-system inflammatory syndrome in children (MIS-C) following SARS-CoV-2 infection: Review of clinical presentation, hypothetical pathogenesis, and proposed management. Children (Basel). 2020;7:69.PubMed Nakra NA, Blumberg DA, Herrera-Guerra A, Lakshminrusimha S. Multi-system inflammatory syndrome in children (MIS-C) following SARS-CoV-2 infection: Review of clinical presentation, hypothetical pathogenesis, and proposed management. Children (Basel). 2020;7:69.PubMed
23.
go back to reference Martínez-García JJ, López-Acosta JR, Arce-Cabrera D, et al. Case report: Multisystem inflammatory syndrome in children associated with COVID-19, macrophage activation syndrome, and incomplete Kawasaki disease. Front Pediatr. 2023;11:1167828.CrossRefPubMedPubMedCentral Martínez-García JJ, López-Acosta JR, Arce-Cabrera D, et al. Case report: Multisystem inflammatory syndrome in children associated with COVID-19, macrophage activation syndrome, and incomplete Kawasaki disease. Front Pediatr. 2023;11:1167828.CrossRefPubMedPubMedCentral
24.
go back to reference James JA, Neas BR, Moser KL, et al. Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure. Arthritis Rheum. 2001;44:1122–6.CrossRefPubMed James JA, Neas BR, Moser KL, et al. Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure. Arthritis Rheum. 2001;44:1122–6.CrossRefPubMed
25.
go back to reference Toussirot É, Roudier J. Epstein-Barr virus in autoimmune diseases. Best Pract Res Clin Rheumatol. 2008;22:883–96.CrossRefPubMed Toussirot É, Roudier J. Epstein-Barr virus in autoimmune diseases. Best Pract Res Clin Rheumatol. 2008;22:883–96.CrossRefPubMed
26.
go back to reference Kang I, Quan T, Nolasco H, et al. Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus. J Immunol. 2004;172:1287–94.CrossRefPubMed Kang I, Quan T, Nolasco H, et al. Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus. J Immunol. 2004;172:1287–94.CrossRefPubMed
Metadata
Title
The Intricate Dance of Infections and Autoimmunity: An Interesting Paradox
Authors
Anand Prahalad Rao
Debasis Patro
Publication date
12-12-2023
Publisher
Springer India
Published in
Indian Journal of Pediatrics
Print ISSN: 0019-5456
Electronic ISSN: 0973-7693
DOI
https://doi.org/10.1007/s12098-023-04928-8